Autopsy report · NCT00046163

A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension

“Study was terminated due to poor enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 11 months before it stopped.
• 150 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Shire

Sponsor type

Industry

Conditions

Hypotension, Orthostatic

Interventions

midodrine hydrochloride (ProAmatine®)

Participants

150

Sites

3

Countries

United States

Trials that died the same way

• Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
  “Study was terminated due to low enrollment” (97% match in meaning)
• Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
  “Study terminated due to low enrollment.” (95% match in meaning)
• The Effect of Blended Sensor Efficiency on Relieving the Heart's Inability to Increase Its Rate During Exercise
  “The study was terminated due to poor enrollment.” (95% match in meaning)
• Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
  “The study was terminated due to low enrollment” (94% match in meaning)
• Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
  “the study was terminated early due to poor enrollment” (94% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.